George Eric Davis insider trades
Open-market stock purchases and sales by George Eric Davis, EVP, Chief Legal Officer at Biomarin Pharmaceutical Inc, from SEC Form 4 filings since Apr 30, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 2, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold | $1.2M |
| Mar 18, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold (not open market) | $71.4K |
| Mar 16, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold (not open market) | $420K |
| Mar 16, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Mar 16, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Feb 26, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold | $1.6M |
| Feb 25, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Feb 25, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Feb 25, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
Companies traded
- BMRN Biomarin Pharmaceutical Inc: 78 sales, last Sep 2, 2026